Capricor Therapeutics, Inc. (CAPR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.34B |
| Enterprise Value | 1.07B |
| P/E Ratio | -3.39 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.95 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.47 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | -0.57 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -100.11M |
| Net Income | -105.04M |
| Diluted EPS | -2.26 |
Balance Sheet
| Total Cash | 237.93M |
| Total Cash/Share | 4.11 |
| Total Debt | 91.05M |
| Total Debt/Equity | 0.37 |
| Current Ratio | 7.35 |
| Book Value Per Share | 4.25 |
Price History
| 52-Week Change | 28.88 |
| 52-Week High | 40.37 |
| 52-Week Low | 2.96 |
| Moving Average 50 Days | 11.93 |
| Moving Average 200 Days | 23.4 |
Statistics
| Average Volume | 6.35M |
| Shares Outstanding | 57.51M |
| % Held by Institutions | 68.17 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 05, 2019 |
AD
